-
BioJet LLC Obtains License for Pharmaceutical Production
Read more: BioJet LLC Obtains License for Pharmaceutical ProductionIn November 2025, the production facility of BioJet LLC in Pechatniki successfully passed an inspection by the Russian Ministry of Industry and Trade. Based on the results, the company was granted a License to manufacture medicinal pharmaceutical products. License registration number: L012-00102-77/03725316, issued on November 13, 2025.
-
Public Procurement of Medicines in Russia Reached 1 Trillion Rubles in 2025
Read more: Public Procurement of Medicines in Russia Reached 1 Trillion Rubles in 2025Public procurement of medicines in Russia totaled 1 trillion rubles in 2025, representing a 26% increase compared with 2024. In physical terms, procurement volumes grew 27% year-on-year to 746 million packages. These figures were presented by Sergey Shulyak, CEO of DSM Group, at the PharmLiga forum in Moscow, GxP News reported. Oncology drugs accounted for…
-
Retail Pharmaceutical Market Value Increased by 13.3% in 2025
Read more: Retail Pharmaceutical Market Value Increased by 13.3% in 2025The value of Russia’s retail pharmaceutical market reached 1.83 trillion rubles in 2025, marking a 13.3% increase year-on-year, according to the press service of the Center for the Development of Advanced Technologies (CRPT), the operator of the national product labeling system. At the same time, sales in physical terms totaled 4.7 billion packages, which is…
-
New Molecules Synthesized in Russia for Next-Generation Medicines
Read more: New Molecules Synthesized in Russia for Next-Generation MedicinesThe compounds could help develop antimicrobial, anticancer, and anti-inflammatory drugs, according to the press service of Reshetnev University in Krasnoyarsk. Scientists at Reshetnev University in Krasnoyarsk have synthesized ten new chemical compounds that could serve as the basis for the development of innovative medicines and materials with unique properties. In particular, these compounds may help…
-
DSM Group Presents Top 10 Russian Pharmaceutical Distributors
Read more: DSM Group Presents Top 10 Russian Pharmaceutical DistributorsAccording to data from DSM Group, the pharmaceutical market volume at distributor prices reached 2.87 trillion rubles in 2025, representing a 19% increase compared to 2024. The main driver of growth was the public sector, which expanded by 26% year-on-year, largely due to increased deliveries to healthcare institutions under contracts signed at the end of…
-
Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030
Read more: Russia Plans to Halve Dependence on Imports of Critical Biocomponents by 2030The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную микробиологию, биополимеры, биотопливо и продукты питания нового поколения, сообщил глава Минпромторга Антон Алиханов. Russia plans to reduce its dependence on imports of critical biotechnological components—such as enzymes, starter cultures, and certain types of protein products—by at least half by 2030.…
-
Alikhanov: At Least 10 Pharmaceutical Manufacturing Facilities to Be Built in Russia by 2030
Read more: Alikhanov: At Least 10 Pharmaceutical Manufacturing Facilities to Be Built in Russia by 2030By 2030, Russia plans to build at least 10 new pharmaceutical manufacturing facilities, Russian Minister of Industry and Trade Anton Alikhanov said at a meeting between President Vladimir Putin and members of the government. “The industrial base of the sector has largely been formed. By 2030, it is planned to build at least 10 additional…
-
Ministry of Industry and Trade: The Share of Domestic Medicines in Russia Has Exceeded 60%
Read more: Ministry of Industry and Trade: The Share of Domestic Medicines in Russia Has Exceeded 60%The share of domestically produced medicines in Russia stands at 63%, and exceeds 80% in government procurement, Russian Minister of Industry and Trade Anton Alikhanov reported at a meeting attended by Russian President Vladimir Putin devoted to the results of the December “Direct Line.” “The expansion of production capacity has enabled us to reach a…
-
Special Procedure for the Sale of Foreign Medicines Extended Until the End of 2027
Read more: Special Procedure for the Sale of Foreign Medicines Extended Until the End of 2027The special procedure for the sale in Russia of registered foreign medicinal products will remain in effect until December 31, 2027, according to the government’s press service. The measure concerns the possibility of selling foreign medicines in their original foreign packaging. “At the same time, the label must be in Russian,” the statement says. The…
-
A Drug for Hepatitis B Therapy Developed in Russia
Read more: A Drug for Hepatitis B Therapy Developed in RussiaRussian scientists have developed a drug for the treatment of hepatitis B based on CRISPR/Cas9 technology. A hepatitis B therapy based on gene-editing technology has been developed in Russia, Sechenov University reported. “We have developed a new non-viral delivery system based on biodegradable nanoparticles. For the first time, we have learned how to package CRISPR/Cas…